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ABSTRACT
The article is aimed at conducting pilot studies of microcirculation changes in patients with diabetes mellitus
during the course of intravenous infusions of alpha lipoic acid. The study was conducted with patients with
diabetes during the passage of a standard course of treatment. The change in parameters was compared before
the start of the infusion course, during and after the course. A system of wearable laser Doppler monitors was used
to conduct the study. The study showed that although the microcirculation index does not undergo significant
changes during the treatment process, spectral analysis of the recorded signal has potential applicability. Further
studies with a larger sample group are required for a qualitative analysis of the observed effects.
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1. INTRODUCTION
Diabetic polyneuropathy (DPN) is one of the common complications of diabetes mellitus (DM), and is also a
leading cause of non-traumatic limb amputation. DM is one of the main causes of neuropathy around the world,
and in particular in industrialized countries.1 Complication is characterized by a complex pathogenetic network
of interconnected metabolic, neurotrophic and vascular defects that cause chronic progressive damage and loss of
non-myelinated and myelinated peripheral nerve fibers.2 The growing incidence of DM raises its complications
to the level of the most important problems of modern healthcare. There is a need for new strategies for the
effective treatment of DM complications and the prevention of their development. In earlier studies, it was shown
that the duration and quality of life of patients with DM largely depend on the presence and degree of chronic
complications.3
There are several types of diabetic neuropathy, which differ in their manifestations and pathogenesis.2 As
a result, various tactics of treating this complication are proposed. Since oxidative stress plays a large role in
the development of diabetic complications, some studies have shown the beneficial effects of antioxidant therapy
on preventing or slowing the development of DPN. Alpha lipoic acid (ALA) is one such substance. It belongs
to a number of strong antioxidants, and also has insulin-like effects. ALA has historically been considered an
excellent antioxidant and oxidative stress neutralizer.4 It has been reported that ALA has a number of potentially
beneficial effects both for the prevention and treatment of diseases associated with peroxidation. Among the
positive effects of ALA is the fact that it can lower levels of C-reactive protein.5
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Clinical trials of the substance showed that ALA significantly improves the symptoms of neuropathy, while its
intravenous administration is more effective than oral administration.6 The best results of therapy are observed
when applying a course of intravenous infusions followed by taking the substance orally.
Studies show that the development of DPN is associated not only with metabolic, but also with vascular
disorders, and in particular with a decrease in nerve blood flow.7,8 Although there have been numerous studies
of changes in symptoms of DPN in the treatment of ALA, studies of the effect of this substance on the state of
microcirculation are limited.9
The aim of this study was to evaluate the change in blood microcirculation parameters during intravenous
infusions of a solution of ALA in patients with type 2 DM using a system of wearable laser Doppler monitors.
2. MATERIALS AND METHODS
Experimental studies were carried out using four wearable laser Doppler flowmetry monitors “AMT-LAZMA
1” (Aston Medical Technology Ltd., UK) for the analysis of blood microcirculation.10 These devices implement
the method of laser Doppler flowmetry (LDF) with simultaneous registration of data from the accelerometer and
skin thermometer. As the emitter in the sensor is used in a vertical-cavity surface-emitting laser (VCSEL) with
a wavelength of 850 nm, the signal receivers are two photodiodes.
The LDF method is based on the light probing of the tissue and subsequent analysis of reflected from moving
red blood cells light. LDF is used for functional diagnostics of the blood microcirculation system, including
diagnostics of socially significant diseases associated with the cardiovascular system.11 In addition, this method
allows one to evaluate oscillatory processes in the microcirculatory bed using data processing by the means of the
Morlet wavelet. There are several frequency ranges that characterize the contribution of various factors to the
LDF signal: endothelial (0.0095-0.021 Hz), neurogenic (0.021-0.052 Hz), myogenic (0.052-0.145 Hz), respiratory
(0.145-0.6 Hz), and cardiac (0.6-2 Hz).12 Analysis of skin blood flow fluctuations significantly aids understanding
the physiological characteristics of the cardiovascular system,13 and allows one to track pathological changes in
various diseases, in particular in rheumatic diseases11 and diabetes.14,15
The research was carried out according to the following scheme shown in the figure 1. Infusion procedures
for patients start from the 2nd day of the patient’s stay in the hospital. Three studies were performed on the
first infusion day using the following algorithm: 10 minutes of recording basal blood flow before infusion, about
20 minutes of recording blood flow during infusion (the recording time may differ slightly between patients), 10
minutes of recording basal blood flow immediately after the infusion procedure. On the second day, a 10-minute
recording of basal blood flow was performed before the second infusion procedure. The last 10-minute recording
of basal blood flow was made on the day after the end of the infusion procedures that is, on the 6th day of the
patient’s stay in the hospital (each patient underwent a course of 5 infusions).
Figure 1. The protocol of the experimental studies
During all recordings, wearable laser analyzers were attached to the plantar side of the big toes and the
palmar surface of the distal phalanx of the 3rd fingers. The patients rested supine. The ALA solution was
infused into the lateral subcutaneous vein of the right or left hand. The choice of hand was determined by the
medical personnel. The study involved 10 patients with type 2 diabetes mellitus (4 men and 6 women, average
age 55.8 ± 14.3).
Proc. of SPIE Vol. 11363  113631K-2
Downloaded From: https://www.spiedigitallibrary.org/conference-proceedings-of-spie on 19 Jan 2021
Terms of Use: https://www.spiedigitallibrary.org/terms-of-use
To detect the body’s response to the course of ALA infusions, the microcirculation index (Im), the amplitudes
of endothelial (E), neurogenic (N), myogenic (M), respiratory (R) and cardiac (C) oscillations, normalized for
standard deviation, were evaluated. To assess the impact of intravenous infusions on the signal registered, all
analyzed parameters were normalized to the data of the first stage (baseline).
3. RESULTS AND DISCUSSION
In this study, long-term monitoring of the microhaemodynamic parameters was carried out during a standard
course of treatment for patients with DM. During the research, the initial values of the measured parameters
were recorded at the time the patient was admitted to the hospital before any therapeutic effects were exerted.
Figure 2. Relative increment of neurogenic (upper panel) and myogenic (lower panel) oscillations measured in the fingers
* - The significance of the difference between the values was confirmed with p < 0.05 according to the Friedman-Anova
test
The index of microcirculation, measured in all 4 areas of the study, showed a tendency to decrease by the time
the therapy is completed. Although there were no statistically significant differences between the measurements
taken before and after therapy, a trend for a slight decrease in microcirculation was observed in all studied
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patients. Taking into account the fact that patients with diabetes are often associated with increased values of
the index of microcirculation in comparison with a healthy controls,14,15 this change can be assumed due to the
positive effects of the therapy provided.
It is interesting to note that during the treatment process significant changes in neurogenic fluctuations
are observed, while the reaction varies for the upper and lower extremities. By the last stage, an increase in
normalized oscillations in the hands is observed, while in the legs there is a trend towards a decrease in this
parameter. Oscillations of the myogenic range, although underwent growth by the time of therapy completion,
did not reach statistically significant differences compared with the first examination. In myogenic oscillations,
different changes were observed in the upper and lower extremities, as indicated above for neurogenic ones. Figure
2 shows the relative increment of neurogenic (upper panel) and myogenic (lower panel) oscillations measured in
the fingers.
It is worth noting that the absence of significant changes in the measured parameters can be correlated
with the short duration of the course of treatment. Indeed, it was noted that a significant improvement in the
symptoms of neuropathy occurs after an 8-week course of treatment using ALA.5 In addition, treatment with
ALA has a cumulative effect and may not appear in the microcirculation parameters during the first week. In
medical practice, mixed courses with consumption of ALA in the form of pills for several weeks after a course of
intravenous infusion are more common and show better results. A promising direction is to study the long-term
effect of ALA intake on the state of microcirculation in patients after undergoing an intravenous infusion course,
which will be the subject of our further studies.
4. CONCLUSION
The presented study demonstrates the possibility of using the LDF method to assess changes in haemodynamic
parameters in the treatment of diabetes complications. It was shown that wearable LDF devices are capable of
the estimating of the microcirculatory parameters during intravenous infusions, as well as of tracing the dynamic
changes in parameters during treatment.
In the present study, it was shown that the use of ALA contributes to a change in the regulation parameters
of microcirculatory blood flow, in particular, fluctuations of the neurogenic and myogenic origin. However, these
observations require further research with a larger sample size and longer monitoring. The research technique
can be applied not only to ALA infusions, but also to study another potential treatment option.
The use of functional tests to assess the reactivity of the microcirculatory system, such as the occlusion test,
local tissue heating, etc., has potential opportunities for a better assessment of the effectiveness of therapy. The
use of functional tests allowing to evaluate the state of microcirculation in dynamics and study its adaptive
properties, which may be impaired as a result of the disease.
Finally, since ALA is an antioxidant and is used to treat metabolic disorders, a multimodal approach using
other biophotonic methods simultaneously in the same diagnostic volume seems to be preferable.
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